Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05096338

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

Cardiotoxicity of Prostate Cancer Therapy: Mechanisms, Predictors, and Social Determinants of Health in Prostate Cancer Patients Treated With Androgen Deprivation Therapy

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Abramson Cancer Center at Penn Medicine · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an observational study for patients with prostate cancer that will be treated with Androgen Deprivation Therapy. The study will help the investigators learn more about how these medications affect the heart and how those effects relate to patients' medical history and social determinants of health (such as race, gender identity, education, occupation, access to health services and economic resources). Patients on this study will have echocardiograms, blood draws, and answer questions about their symptoms and activity level. Patients will be followed on this study for up to 5 years.

Detailed description

The investigators propose a prospective longitudinal cohort of prostate cancer patients treated with Androgen Deprivation Therapy (ADT) to determine the associations between social determinants of health (SDOH) and cardiotoxicity risk and to determine wither associations between SDOH and cardiotoxicity risk differs according to race. Patients will be followed with serial echo, blood draw, and surveys prior to start of ADT and then 6 months, 1 year, 2 years, 3 years, and 5 years after start of ADT.

Conditions

Interventions

TypeNameDescription
OTHERSocial Determinants of HealthWe will perform detailed phenotyping of Social Determinants of Health using the National Institute of Minority Health and Health Disparities PhenX SDOH toolkit at baseline.

Timeline

Start date
2021-10-27
Primary completion
2029-11-01
Completion
2029-11-01
First posted
2021-10-27
Last updated
2026-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05096338. Inclusion in this directory is not an endorsement.